Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Schold

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Neurology|October 27, 1997
Challenges in the design and conduct of phase III brain tumor therapy trialsJ R Perry, L M DeAngelis, S C Schold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Phase II study of paclitaxel in patients with recurrent malignant gliomaM D Prados, S C Schold, A M Spence, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase II study of phenylacetate in patients with recurrent malignant glioma: a North American Brain Tumor Consortium reportS M Chang, J G Kuhn, H I Robins, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Intracellular Localization and intercellular heterogeneity of the human DNA repair protein O(6)-methylguanine-DNA methyltransferaseM Belanich, T Randall, M A Pastor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium reportS M Chang, J G Kuhn, J Rizzo, et al.
Cancer Research|July 15, 1997
Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograftH S Friedman, S P Johnson, Q Dong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant gliomaH S Friedman, D M Kokkinakis, J Pluda, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1996
A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. CNS Cancer ConsortiumE C Halperin, J Herndon, S C Schold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial resultsM T Brown, R E Coleman, A H Friedman, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Neurology|October 27, 1997
Challenges in the design and conduct of phase III brain tumor therapy trialsJ R Perry, L M DeAngelis, S C Schold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Phase II study of paclitaxel in patients with recurrent malignant gliomaM D Prados, S C Schold, A M Spence, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase II study of phenylacetate in patients with recurrent malignant glioma: a North American Brain Tumor Consortium reportS M Chang, J G Kuhn, H I Robins, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Intracellular Localization and intercellular heterogeneity of the human DNA repair protein O(6)-methylguanine-DNA methyltransferaseM Belanich, T Randall, M A Pastor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium reportS M Chang, J G Kuhn, J Rizzo, et al.
Cancer Research|July 15, 1997
Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograftH S Friedman, S P Johnson, Q Dong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant gliomaH S Friedman, D M Kokkinakis, J Pluda, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1996
A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. CNS Cancer ConsortiumE C Halperin, J Herndon, S C Schold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial resultsM T Brown, R E Coleman, A H Friedman, et al.
Pageof 13